The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients. Gostelie R, Stegeman I, Berkers G, Bittermann J, et al. PLoS One 2020;15:e0235638.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gostelie R, Stegeman I, Berkers G, Bittermann J, et al. The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients. PLoS One 2020;15:e0235638.
PMID: 32687499